|
ASX - By Stock
|
CYP |
Re:
Best Advertising Without Ringing A Bell
|
|
mcnamm
|
57 |
15K |
17 |
19/04/26 |
| 19/04/26 |
ASX - By Stock
|
57
|
15K
|
17
|
|
|
ASX - By Stock
|
CYP |
Re:
Moving North
|
|
mcnamm
|
129 |
33K |
9 |
17/01/26 |
| 17/01/26 |
ASX - By Stock
|
129
|
33K
|
9
|
|
|
ASX - By Stock
|
CYP |
Re:
Moving North
|
|
mcnamm
|
129 |
33K |
3 |
17/01/26 |
| 17/01/26 |
ASX - By Stock
|
129
|
33K
|
3
|
|
|
ASX - By Stock
|
CYP |
Re:
Moving North
|
|
mcnamm
|
129 |
33K |
9 |
17/01/26 |
| 17/01/26 |
ASX - By Stock
|
129
|
33K
|
9
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Recruitment Completed in Phase 3 OA Clinical Trial
|
|
mcnamm
|
54 |
20K |
18 |
23/10/25 |
| 23/10/25 |
ASX - By Stock
|
54
|
20K
|
18
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Expiry of listed CYPOA Options
|
|
mcnamm
|
8 |
3.5K |
5 |
25/03/25 |
| 25/03/25 |
ASX - By Stock
|
8
|
3.5K
|
5
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Presenting at Advanced Therapies Congress
|
|
mcnamm
|
3 |
1.9K |
10 |
19/03/25 |
| 19/03/25 |
ASX - By Stock
|
3
|
1.9K
|
10
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Publication comparing Cymerus MSCs to other MSCs
|
|
mcnamm
|
72 |
18K |
5 |
11/02/25 |
| 11/02/25 |
ASX - By Stock
|
72
|
18K
|
5
|
|
|
ASX - By Stock
|
CYP |
Re:
Voting Against Resolution 1 - Adoption of Remuneration Report
|
|
mcnamm
|
1 |
601 |
3 |
09/11/24 |
| 09/11/24 |
ASX - By Stock
|
1
|
601
|
3
|
|
|
ASX - By Stock
|
CYP |
Voting Against Resolution 1 - Adoption of Remuneration Report
|
|
mcnamm
|
1 |
601 |
8 |
09/11/24 |
| 09/11/24 |
ASX - By Stock
|
1
|
601
|
8
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
mcnamm
|
614 |
158K |
10 |
11/06/24 |
| 11/06/24 |
ASX - By Stock
|
614
|
158K
|
10
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
mcnamm
|
614 |
158K |
15 |
02/06/24 |
| 02/06/24 |
ASX - By Stock
|
614
|
158K
|
15
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Encouraging Initial Data from CYP-006TK DFU Trial
|
|
mcnamm
|
49 |
14K |
6 |
27/02/24 |
| 27/02/24 |
ASX - By Stock
|
49
|
14K
|
6
|
|
|
ASX - By Stock
|
CYP |
Re:
TA
|
|
mcnamm
|
21 |
7.3K |
4 |
24/02/24 |
| 24/02/24 |
ASX - By Stock
|
21
|
7.3K
|
4
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 4D & Half-Year Financial Statements
|
|
mcnamm
|
1 |
1.1K |
13 |
24/02/24 |
| 24/02/24 |
ASX - By Stock
|
1
|
1.1K
|
13
|
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
11K |
10 |
10/11/23 |
| 10/11/23 |
ASX - By Stock
|
43
|
11K
|
10
|
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
11K |
8 |
06/11/23 |
| 06/11/23 |
ASX - By Stock
|
43
|
11K
|
8
|
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
11K |
10 |
06/11/23 |
| 06/11/23 |
ASX - By Stock
|
43
|
11K
|
10
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 SCUlpTOR Osteoarthritis Clinical Trial Progress
|
|
mcnamm
|
6 |
2.4K |
13 |
06/11/23 |
| 06/11/23 |
ASX - By Stock
|
6
|
2.4K
|
13
|
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
11K |
6 |
03/11/23 |
| 03/11/23 |
ASX - By Stock
|
43
|
11K
|
6
|
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
11K |
7 |
02/11/23 |
| 02/11/23 |
ASX - By Stock
|
43
|
11K
|
7
|
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
11K |
3 |
02/11/23 |
| 02/11/23 |
ASX - By Stock
|
43
|
11K
|
3
|
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
11K |
10 |
31/10/23 |
| 31/10/23 |
ASX - By Stock
|
43
|
11K
|
10
|
|
|
ASX - By Stock
|
CYP |
AGM voting
|
|
mcnamm
|
43 |
11K |
11 |
30/10/23 |
| 30/10/23 |
ASX - By Stock
|
43
|
11K
|
11
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
mcnamm
|
394 |
102K |
8 |
15/02/23 |
| 15/02/23 |
ASX - By Stock
|
394
|
102K
|
8
|
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
mcnamm
|
2.1K |
770K |
14 |
23/01/23 |
| 23/01/23 |
ASX - By Stock
|
2.1K
|
770K
|
14
|
|
|
ASX - By Stock
|
CYP |
Re:
AGM Resolutions
|
|
mcnamm
|
115 |
21K |
2 |
04/11/21 |
| 04/11/21 |
ASX - By Stock
|
115
|
21K
|
2
|
|
|
ASX - By Stock
|
CYP |
AGM Resolutions
|
|
mcnamm
|
115 |
21K |
24 |
04/11/21 |
| 04/11/21 |
ASX - By Stock
|
115
|
21K
|
24
|
|
|
ASX - By Stock
|
CYP |
Re:
EGM campaign
|
|
mcnamm
|
75 |
20K |
2 |
20/08/21 |
| 20/08/21 |
ASX - By Stock
|
75
|
20K
|
2
|
|
|
ASX - By Stock
|
CYP |
Re:
EGM campaign
|
|
mcnamm
|
75 |
20K |
14 |
16/08/21 |
| 16/08/21 |
ASX - By Stock
|
75
|
20K
|
14
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Enrolled in Cynata MEND Clinical Trial
|
|
mcnamm
|
183 |
45K |
15 |
16/07/21 |
| 16/07/21 |
ASX - By Stock
|
183
|
45K
|
15
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Enrolled in Cynata MEND Clinical Trial
|
|
mcnamm
|
183 |
45K |
12 |
16/07/21 |
| 16/07/21 |
ASX - By Stock
|
183
|
45K
|
12
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Letter to Optionholders
|
|
mcnamm
|
237 |
42K |
19 |
16/12/20 |
| 16/12/20 |
ASX - By Stock
|
237
|
42K
|
19
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Technology Featured on Front Cover of Nature Medicine
|
|
mcnamm
|
184 |
40K |
4 |
18/11/20 |
| 18/11/20 |
ASX - By Stock
|
184
|
40K
|
4
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Date of AGM & Closing Date for Director Nominations
|
|
mcnamm
|
44 |
12K |
9 |
13/10/20 |
| 13/10/20 |
ASX - By Stock
|
44
|
12K
|
9
|
|
|
ASX - By Stock
|
CYP |
Re:
CYP vs MSB
|
|
mcnamm
|
644 |
135K |
15 |
29/09/20 |
| 29/09/20 |
ASX - By Stock
|
644
|
135K
|
15
|
|
|
ASX - By Stock
|
CYP |
Re:
Wotton's Time is Now
|
|
mcnamm
|
69 |
40K |
19 |
18/08/20 |
| 18/08/20 |
ASX - By Stock
|
69
|
40K
|
19
|
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
mcnamm
|
507 |
1.6M |
5 |
25/06/20 |
| 25/06/20 |
ASX - By Stock
|
507
|
1.6M
|
5
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoff Brooke
|
|
mcnamm
|
5 |
2.4K |
3 |
24/06/20 |
| 24/06/20 |
ASX - By Stock
|
5
|
2.4K
|
3
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
mcnamm
|
495 |
132K |
12 |
21/06/20 |
| 21/06/20 |
ASX - By Stock
|
495
|
132K
|
12
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
mcnamm
|
495 |
132K |
9 |
21/06/20 |
| 21/06/20 |
ASX - By Stock
|
495
|
132K
|
9
|
|
|
ASX - By Stock
|
CYP |
Re:
SPP chances of getting full allotment
|
|
mcnamm
|
86 |
25K |
15 |
27/05/20 |
| 27/05/20 |
ASX - By Stock
|
86
|
25K
|
15
|
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata MSCs beneficial in preclinical ARDS study
|
|
mcnamm
|
99 |
28K |
27 |
17/04/20 |
| 17/04/20 |
ASX - By Stock
|
99
|
28K
|
27
|
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
mcnamm
|
133 |
33K |
14 |
09/04/20 |
| 09/04/20 |
ASX - By Stock
|
133
|
33K
|
14
|
|
|
ASX - By Stock
|
CYP |
Re:
Please explain
|
|
mcnamm
|
6 |
2.6K |
9 |
18/03/20 |
| 18/03/20 |
ASX - By Stock
|
6
|
2.6K
|
9
|
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
mcnamm
|
507 |
1.6M |
7 |
15/02/20 |
| 15/02/20 |
ASX - By Stock
|
507
|
1.6M
|
7
|
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
mcnamm
|
507 |
1.6M |
9 |
15/02/20 |
| 15/02/20 |
ASX - By Stock
|
507
|
1.6M
|
9
|
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
mcnamm
|
507 |
1.6M |
9 |
15/02/20 |
| 15/02/20 |
ASX - By Stock
|
507
|
1.6M
|
9
|
|
|
ASX - By Stock
|
CYP |
Re:
Mcnamm
|
|
mcnamm
|
28 |
23K |
29 |
15/02/20 |
| 15/02/20 |
ASX - By Stock
|
28
|
23K
|
29
|
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
mcnamm
|
2.1K |
770K |
13 |
17/12/19 |
| 17/12/19 |
ASX - By Stock
|
2.1K
|
770K
|
13
|
|